Four teams of researchers at Columbia University have been awarded 2023 Edward P. Evans Center for Myelodysplastic Syndromes (MDS) Pilot Awards and Fellowships
A new three-year, $2.5 million grant from Stand Up to Cancer (SU2C) has been awarded to a multi-institutional team of gastroesophageal cancer experts, led by HICCC director Anil K. Rustgi, MD.
The CZI Diversity award recognizes the Azizi lab with a new $1.15M grant and underscores Dr. Azizi's commitment to improving diversity and inclusion in cancer science, engineering, and research.
A congratulations to Dr. Gaublomme who has received a prestigious NIH Director's New Innovator Award for work that pushes the boundaries in cancer research.
Congratulations to Lauren Houghton, Chin Hur, Markus D. Siegelin, and Neil Vasan, the new Class of Velocity Fellows, for their innovative, life-changing cancer research.
New awards program supports cutting-edge research dedicated to the study and treatment of MDS, a malignant disease that attacks bone marrow stem cells.
With a new three-year, $775,000 Translational Research Program grant by The Leukemia & Lymphoma Society, Dr. Lentzsch and collaborators unveil a promising new approach to treat multiple myeloma.
Columbia Cancer congratulates Drs. Catherine Spina and Aaron Viny, recipients of a prestigious Clinical Scientist Development Award by the Doris Duke Charitable Foundation.
Annual Precision Medicine Pilot Grants are awarded to five Columbia research teams, including research led by members Drs. Brent Stockwell and Kelley Yan.